We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




AI-Powered Prostate Cancer Diagnosis Tool Accurately Identifies and Classifies Tumors

By LabMedica International staff writers
Posted on 14 Mar 2023
Print article
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)
Image: QAi Prostate is an advanced AI-powered prostate cancer diagnosis tool for pathologists (Photo courtesy of Qritive)

Prostate adenocarcinoma is the most prevalent form of prostate cancer, representing around 90% of all prostate cases, and is also the second most commonly occurring cancer in men, demonstrating a steady increase in prevalence worldwide. Now, a powerful tool to detect prostatic adenocarcinoma leverages advanced machine learning algorithms to accurately identify and classify malignant and benign areas in prostate biopsies, thereby improving diagnostic accuracy and patient outcomes.

Qritive (Singapore) has launched a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis that uses advanced machine learning algorithms to analyze whole slide images of prostate core needle biopsies, identify prostatic adenocarcinoma region, and segment and classify them into benign and malignant areas. QAi Prostate uses whole slide images as well as regions of interest (ROI) for screening adenocarcinoma. QAi Prostate provides a detailed summary of the tumor size and percentage for each slide or ROI, allowing pathologists to quickly make more informed and accurate diagnoses, thus reducing the time to treatment for patients.

QAi Prostate has been built using a comprehensive dataset that has passed through extensive testing and validation procedures to ensure it meets the required clinical metrics and reliability standards. It is compatible with all standard digital pathology systems and can be easily integrated into existing workflows using Open API interface through a customizable middleware. It allows for secured communication using standard SSL encryption and the middleware as a single point of entry with role-based access to ensure advanced security and compliance. QAi Prostate is currently not approved by the FDA or CE marked and can be deployed for research use or as laboratory developed test only.

"We are excited to introduce this new AI module for prostate cancer diagnosis," said Dr. Kaveh Taghipour, CTO of Qritive. "QAi Prostate has been developed using millions of data points and thousands of hours of expert knowledge. This technology has the potential to improve the accuracy and speed of prostate cancer diagnosis significantly, leading to better outcomes for patients."

Related Links:
Qritive 

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
HbA1c Test
HbA1c Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.